Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $20,050 | $4,378 | $163 |
| - Cash | $4,036 | $1,669 | $5,055 | $5,971 |
| + Debt | $501 | $727 | $382 | $464 |
| Enterprise Value | -$3,535 | $19,108 | -$295 | -$5,344 |
| Revenue | $0 | $0 | $0 | $83 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$1,665 | -$3,248 | -$2,189 | -$2,168 |
| % Margin | – | – | – | -2,612% |
| EBITDA | -$3,945 | -$4,927 | -$3,248 | -$2,287 |
| % Margin | – | – | – | -2,755.4% |
| Net Income | -$3,806 | -$2,421 | -$3,308 | -$3,511 |
| % Margin | – | – | – | -4,230.1% |
| EPS Diluted | -150,600 | -36,500 | -79,200 | -11,300 |
| % Growth | -312.6% | 53.9% | -600.9% | – |
| Operating Cash Flow | -$3,304 | -$7,454 | -$4,807 | -$2,945 |
| Capital Expenditures | -$2 | -$774 | $0 | -$22 |
| Free Cash Flow | -$3,306 | -$8,228 | -$4,807 | -$2,967 |